NTP-TELMISARTAN 80 MG — DIN 02388731
TELMISARTAN : 80 MG · TEVA CANADA LIMITED · TABLET · wholesale supply in Canada
Health Canada status: CANCELLED PRE MARKET
What is NTP-TELMISARTAN?
NTP-TELMISARTAN 80 MG contains TELMISARTAN : 80 MG. It is listed in the Health Canada Drug Product Database under DIN 02388731, held by TEVA CANADA LIMITED, supplied as TABLET for ORAL administration. Health Canada currently lists it as cancelled pre market, status dated 13-Jun-2017. This Drug Identification Number is no longer authorized for sale in Canada, so Nexara does not supply it. The record is kept here because buyers still meet the number on old formularies, purchase orders and tender documents; Nexara can help identify an authorized alternative.
What is NTP-TELMISARTAN used for?
NTP-TELMISARTAN tablets are indicated for the treatment of mild to moderate essential hypertension. NTP-TELMISARTAN may be used alone or in combination with thiazide diuretics.
Authorized indication as written in the Health Canada product monograph. For healthcare professionals and licensed purchasers; this is not medical advice.
How much does Telmisartan cost around the world?
Telmisartan is listed on 21 of the national price registers Nexara ingests. Each country publishes on a different basis, so those figures are not comparable with one another — or with a Canadian wholesale price.
What a market publishes matters more than the number it publishes. Australia publishes a ex-manufacturer; Austria publishes a KVP (Kassenverkaufspreis); Bahrain publishes a retail (max). Comparing an ex-factory ceiling against a pharmacy public price tells you nothing about either, and comparing either against a Canadian landed cost tells you less.
| Market | Price basis published there | Brands | Packs listed | Range |
|---|---|---|---|---|
| Spain | PVP con IVA (public price) | 84 | 91 | EUR███.██ |
| Australia | ex-manufacturer | 30 | 88 | AUD███.██ |
| South Africa | single exit price | 76 | 81 | ZAR███.██ |
| Czechia | max producer price (ex-factory) | 20 | 72 | CZK███.██ |
| United States | acquisition | 3 | 62 | USD███.██ |
| Italy | prezzo al pubblico (classe A) | 11 | 31 | EUR███.██ |
| Norway | max AUP (pharmacy retail) | 6 | 30 | NOK███.██ |
| Sweden | AIP (pharmacy purchase price) | 9 | 27 | SEK███.██ |
| Austria | KVP (Kassenverkaufspreis) | 26 | 26 | EUR███.██ |
| Luxembourg | reimbursement | 23 | 23 | EUR███.██ |
| Slovakia | categorised final price | 15 | 23 | EUR███.██ |
| Saudi Arabia | public | 12 | 22 | SAR███.██ |
| Bahrain | retail (max) | 10 | 18 | BHD███.██ |
| Hungary | producer price (ex-factory) | 14 | 14 | HUF███.██ |
| United Arab Emirates | public | 13 | 13 | AED███.██ |
| Belgium | public | 8 | 8 | EUR███.██ |
| Romania | max producer price | 7 | 7 | RON███.██ |
| Greece | producer price (ex-factory) | 4 | 4 | EUR███.██ |
| Morocco | PPV (public price) | 1 | 4 | MAD███.██ |
| United Kingdom | hospital | 3 | 3 | GBP███.██ |
| Iceland | max wholesale | 2 | 2 | ISK███.██ |
649 pack listings across 377 brand entries and 18 price bases, refreshed 08 Sep 2026. Ranges span every Telmisartan pack in that market, so a high figure is usually a larger pack rather than the same product.
This table is a regulatory record of where the molecule is listed. The DIN on this page is no longer authorized for sale in Canada, so Nexara does not quote it — see the alternatives above.
Is there a generic Telmisartan in Canada, and who makes it?
Every market authorization holder with a Canadian DIN for this molecule, and how many of their listings Health Canada currently shows as marketed.
23 holders have a Canadian DIN containing Telmisartan, across 52 DINs, of which 26 are currently marketed. Marketed count is the number that matters: an approval that is not marketed cannot be bought.
| Market authorization holder | DINs | Marketed | Brand names | Position |
|---|---|---|---|---|
| PHARMASCIENCE INC | 6 | 2 | PHARMA-TELMISARTAN, PMS-TELMISARTAN, TELMISARTAN | Sourceable in Canada |
| TEVA CANADA LIMITED | 4 | 2 | NTP-TELMISARTAN, TEVA-TELMISARTAN | Sourceable in Canada |
| ACCORD HEALTHCARE INC | 2 | 2 | ACH-TELMISARTAN | Sourceable in Canada |
| ANGITA PHARMA INC. | 2 | 2 | AG-TELMISARTAN | Sourceable in Canada |
| AURO PHARMA INC | 2 | 2 | AURO-TELMISARTAN | Sourceable in Canada |
| BOEHRINGER INGELHEIM (CANADA) LTD LTEE | 2 | 2 | MICARDIS 40MG TAB, MICARDIS 80MG TAB | Sourceable in Canada |
| JAMP PHARMA CORPORATION | 2 | 2 | JAMP TELMISARTAN | Sourceable in Canada |
| MINT PHARMACEUTICALS INC | 2 | 2 | MINT-TELMISARTAN | Sourceable in Canada |
| NORA PHARMA INC | 2 | 2 | NRA-TELMISARTAN | Sourceable in Canada |
| SANDOZ CANADA INCORPORATED | 2 | 2 | SANDOZ TELMISARTAN | Sourceable in Canada |
| SANIS HEALTH INC | 2 | 2 | TELMISARTAN | Sourceable in Canada |
| SIVEM PHARMACEUTICALS ULC | 2 | 2 | TELMISARTAN | Sourceable in Canada |
Health Canada’s Drug Product Database does not flag which listing is the originator and which are subsequent-entry products, so Nexara does not label them here. Interchangeability is determined provincially, not federally — confirm for your province before a formulary switch. Nexara can confirm which of these is actually obtainable, and on what lead time, per order.
How is it supplied and stored?
Pack configuration, storage class and the handling constraints that drive cold-chain planning. One DIN can cover more than one pack size, and the pack — not the DIN — is what gets priced, shipped and invoiced.
| Strength on the label | 80 MG |
|---|---|
| Dosage form | TABLET |
| Route | ORAL |
| Pack configuration (monograph) | null |
| Storage | null |
Pack detail is kept as a regulatory record. This DIN is no longer authorized for sale in Canada, so Nexara does not quote this pack.
Substance and classification
| Active substance | Telmisartan |
|---|---|
| ATC code | C09CA07 |
| AHFS class | 24:32.08 |
| Biosimilar biologic | No |
Health Canada record and identifiers
The regulatory facts straight from the Drug Product Database, plus every identifier form Nexara accepts on a purchase order. A DIN written without its leading zeros is the commonest reason an order line fails to match.
| DIN (8-digit, as used in ordering) | 02388731 |
|---|---|
| DIN (unpadded, as printed on some documents) | 2388731 |
| Brand name | NTP-TELMISARTAN |
| Generic / active ingredient | TELMISARTAN : 80 MG |
| Market authorization holder | TEVA CANADA LIMITED |
| Health Canada schedule | Prescription |
| ATC code | C09CA07 |
| ATC anatomical main group | C — Cardiovascular system |
| ATC therapeutic subgroup | C09CA |
| Current status | CANCELLED PRE MARKET |
| Status date | 13-Jun-2017 |
| Status source | Live Health Canada DPD sync |
Verify on the primary sources
Is Telmisartan in shortage in Canada?
A Canadian shortage report is on file for a product containing this molecule: Resolved — reported by SIVEM PHARMACEUTICALS ULC, last seen 13 May 2026. A shortage on one presentation does not always affect every DIN of the molecule — the alternatives below list what else is marketed in Canada. Nexara can confirm current availability and identify substitutions or import options where permitted.
What can be used instead?
Alternatives on every axis a buyer actually considers — the same molecule in another presentation, the same class, an adjacent class, or a fixed-dose combination. Every row is led by the marketed DIN count, because that is what can be bought this week.
1 · Same molecule, other Canadian presentations
26 of 52 Canadian DINs for this molecule are currently marketed. Marketed products are listed first.
| Product | Strength | Form | Holder | Health Canada status | DIN |
|---|---|---|---|---|---|
| ACH-TELMISARTAN | 80 MG | TABLET | ACCORD HEALTHCARE INC | MARKETED | 02407493 |
| ACH-TELMISARTAN | 40 MG | TABLET | ACCORD HEALTHCARE INC | MARKETED | 02407485 |
| AG-TELMISARTAN | 40 MG | TABLET | ANGITA PHARMA INC. | MARKETED | 02484536 |
| AG-TELMISARTAN | 80 MG | TABLET | ANGITA PHARMA INC. | MARKETED | 02484544 |
| AURO-TELMISARTAN | 40 MG | TABLET | AURO PHARMA INC | MARKETED | 02453568 |
| AURO-TELMISARTAN | 80 MG | TABLET | AURO PHARMA INC | MARKETED | 02453576 |
| JAMP TELMISARTAN | 80 MG | TABLET | JAMP PHARMA CORPORATION | MARKETED | 02386763 |
| JAMP TELMISARTAN | 40 MG | TABLET | JAMP PHARMA CORPORATION | MARKETED | 02386755 |
| MICARDIS 40MG TAB | 40 MG | TABLET | BOEHRINGER INGELHEIM (CANADA) LTD LTEE | MARKETED | 02240769 |
| MICARDIS 80MG TAB | 80 MG | TABLET | BOEHRINGER INGELHEIM (CANADA) LTD LTEE | MARKETED | 02240770 |
2 · Same class — other molecules in ATC C09CA
| Molecule | Canadian brands | DINs | Marketed | Sourceable |
|---|---|---|---|---|
| Candesartan | ACCEL-CANDESARTAN · ACH-CANDESARTAN · ACT CANDESARTAN · AG-CANDESARTAN · +24 more | 126 | 51 | Yes |
| Irbesartan | ACT IRBESARTAN · AG-IRBESARTAN · APO-IRBESARTAN · AURO-IRBESARTAN · +23 more | 103 | 38 | Yes |
| Valsartan | ACT VALSARTAN · APO-VALSARTAN · AURO-VALSARTAN · AVA-VALSARTAN · +17 more | 85 | 31 | Yes |
| Losartan | ACT LOSARTAN · AG-LOSARTAN · APO-LOSARTAN · AURO-LOSARTAN · +18 more | 81 | 27 | Yes |
| Telmisartan | ACH-TELMISARTAN · ACT TELMISARTAN · AG-TELMISARTAN · ALEMBIC-TELMISARTAN · +20 more | 52 | 26 | Yes |
| Olmesartan Medoxomil | ACH-OLMESARTAN · AG-OLMESARTAN · APO-OLMESARTAN · AURO-OLMESARTAN · +12 more | 42 | 22 | Yes |
| Azilsartan Medoxomil | AURO-AZILSARTAN MEDOXOMIL · EDARBI | 4 | 4 | Yes |
| Eprosartan | TEVETEN · TEVETEN TABLETS 300 MG | 3 | 0 | Not in Canada |
A molecule with zero marketed DINs cannot be sourced domestically, however many approvals it holds — if one of these sits on a formulary or in an older protocol, that is the line to check.
Not clinical advice. These tables describe what can be supplied in Canada, not what should be prescribed. Substitution within or across classes is a prescriber and pharmacist decision, and interchangeability is determined provincially.
What else is NTP-TELMISARTAN called?
The same molecule, Telmisartan, is registered under other names elsewhere. Buyers and prescribers searching from outside Canada — or working from a foreign prescription or tender document — often know it by one of these:
| Name | Script | Registered in |
|---|---|---|
| Micardis | Latin | Australia, Bahrain, Czechia, Morocco, Norway |
| MicardisPlus | Latin | Czechia, Norway, Sweden |
| TELMISARTAN/HYDROCHLOROTHIAZID AUXILTO | Latin | Czechia |
| Tolucombi | Latin | Czechia, Norway, Sweden |
| Tolura | Latin | Czechia, Norway, Sweden |
| ARX-Telmisartan/Amlodipine | Latin | Australia |
| Telmisartan/Amlodipine Viatris | Latin | Australia |
| TEZEO HCT | Latin | Czechia |
| Micardis® | Latin | Sweden |
| Telmisartan Sandoz | Latin | Australia, Czechia |
| Telmisartan/HCT Sandoz | Latin | Australia |
| TELMISARTAN/HYDROCHLOROTHIAZID ZENTIVA | Latin | Czechia |
| TWYNSTA | Latin | Bahrain, Czechia, Saudi Arabia |
| TEZEFORT | Latin | Czechia |
| APO-Telmisartan | Latin | Australia |
Names are taken from national medicine registers and published price lists. A product registered abroad is not authorized for sale in Canada unless it holds its own DIN; import is possible only through the routes Health Canada permits.
Can this still be bought in Canada?
No. This Drug Identification Number is cancelled pre market in Health Canada's Drug Product Database, so the product is no longer authorized for sale in Canada and Nexara does not supply it. This page is kept as a regulatory record.
If you are looking for a current equivalent, the alternatives above list every product sharing this therapeutic class, with the marketed ones first. Ask us to source an alternative
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address. Patients and unlicensed buyers are routed to a partner pharmacy.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Why is there no price on this page?
Nexara quotes a delivered Canadian price per order, against a verified licence. Foreign list prices are published on incompatible bases and are not a guide to what any buyer can obtain here, so this page shows which markets list the molecule and on what basis, and nothing more.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.